IPO - APPLIED DNA SCIENCES INC

Form Type: S-1/A

Filing Date: 2025-01-10

Corporate Action: Ipo

Type: Update

Accession Number: 000110465925002521

Filing Summary: Applied DNA Sciences, Inc. filed an amended S-1 registration statement for a public offering of securities, indicating the potential sale of up to 41,640,625 shares of common stock to be made available through the exercise of outstanding warrants. This includes 20,312,500 Series C Warrants, 20,312,500 Series D Warrants, and 1,015,625 Placement Agent Warrants. The offering is part of ongoing capital-raising efforts to fund further business operations and potentially facilitate expansion into the growing market for mRNA and DNA-based therapeutics, as the company develops synthetic DNA products for use in various medical applications. The company plans to hold a special meeting on January 23, 2025, to gain necessary stockholder approvals and the registration statement amendment reflects updates to its intended offerings and details about its therapeutic DNA Production Services.

Document Link: View Document